Loading company…
NDPHARM develops and manufactures injectable medicines and pharmaceutical ingredients.
Established in 1998 and based in Nanjing, NDPHARM develops, manufactures, and markets injectable urokinase and small-molecule heparin sodium APIs. Its products also include povidone-iodine preparations, thrombin, vitamins, oxytetracycline sodium, and urokinase for injection. In July 2022, it raised strategic funding from Jiangsu Aidea Pharmaceutical Co., Ltd.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in